These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16252016)

  • 1. Bimatoprost: mechanism of ocular surface hyperemia associated with topical therapy.
    Chen J; Dinh T; Woodward DF; Holland M; Yuan YD; Lin TH; Wheeler LA
    Cardiovasc Drug Rev; 2005; 23(3):231-46. PubMed ID: 16252016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost.
    DuBiner H; Cooke D; Dirks M; Stewart WC; VanDenburgh AM; Felix C
    Surv Ophthalmol; 2001 May; 45 Suppl 4():S353-60. PubMed ID: 11434938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of hyperemia associated with bimatoprost treatment in naïve subjects and in subjects previously treated with latanoprost.
    Kurtz S; Mann O
    Eur J Ophthalmol; 2009; 19(3):400-3. PubMed ID: 19396785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.
    Noecker RS; Dirks MS; Choplin NT; Bernstein P; Batoosingh AL; Whitcup SM;
    Am J Ophthalmol; 2003 Jan; 135(1):55-63. PubMed ID: 12504698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
    Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.
    Gandolfi SA; Cimino L
    Ophthalmology; 2003 Mar; 110(3):609-14. PubMed ID: 12623831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
    Easthope SE; Perry CM
    Drugs Aging; 2002; 19(3):231-48. PubMed ID: 12027782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: results from parallel-group comparison trials.
    Simmons ST; Dirks MS; Noecker RJ
    Adv Ther; 2004; 21(4):247-62. PubMed ID: 15605619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure.
    Sherwood M; Brandt J;
    Surv Ophthalmol; 2001 May; 45 Suppl 4():S361-8. PubMed ID: 11434939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.
    Parrish RK; Palmberg P; Sheu WP;
    Am J Ophthalmol; 2003 May; 135(5):688-703. PubMed ID: 12719078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost.
    Stewart WC; Kolker AE; Stewart JA; Leech J; Jackson AL
    Am J Ophthalmol; 2003 Mar; 135(3):314-20. PubMed ID: 12614748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertension.
    Abelson MB; Mroz M; Rosner SA; Dirks MS; Hirabayashi D
    Adv Ther; 2003; 20(1):1-13. PubMed ID: 12772813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjunctival hyperemia associated with bimatoprost use: a histopathologic study.
    Leal BC; Medeiros FA; Medeiros FW; Santo RM; Susanna R
    Am J Ophthalmol; 2004 Aug; 138(2):310-3. PubMed ID: 15289152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.
    Konstas AG; Katsimbris JM; Lallos N; Boukaras GP; Jenkins JN; Stewart WC
    Ophthalmology; 2005 Feb; 112(2):262-6. PubMed ID: 15691561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparative switch study from timolol 0.5% and latanoprost 0.005% to bimatoprost 0.03%.
    Brittain CJ; Saxena R; Waldock A
    Adv Ther; 2006; 23(1):68-73. PubMed ID: 16644608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension.
    Gandolfi S; Simmons ST; Sturm R; Chen K; VanDenburgh AM;
    Adv Ther; 2001; 18(3):110-21. PubMed ID: 11571823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertension.
    Crichton AC; Vold S; Williams JM; Hollander DA
    Adv Ther; 2013 Mar; 30(3):260-70. PubMed ID: 23475405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.
    Eisenberg DL; Toris CB; Camras CB
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S105-15. PubMed ID: 12204706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study.
    Casson RJ; Liu L; Graham SL; Morgan WH; Grigg JR; Galanopoulos A; Crawford A; House PH
    J Glaucoma; 2009; 18(8):582-8. PubMed ID: 19826386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of 13 randomized controlled trials comparing bimatoprost with latanoprost in patients with elevated intraocular pressure.
    Cheng JW; Wei RL
    Clin Ther; 2008 Apr; 30(4):622-32. PubMed ID: 18498911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.